Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Radiation Oncology (London, England)|April 26, 2014
Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factorsPatrizia Ciammella, Ala Podgornii, Maria Galeandro, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 16, 2017
Knowledge-based treatment planning: An inter-technique and inter-system feasibility study for prostate cancerElisabetta Cagni, Andrea Botti, Renato Micera, et al.Tumori|October 3, 2015
The key role of 18F-FDG PET/CT for correct diagnosis, staging, and treatment in a patient with simultaneous NPC and TB lymphadenitis: case reportRenato Micera, Nicola Simoni, Mario De Liguoro, et al.In Vivo (Athens, Greece)|April 17, 2009
11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary resultsGiulia Ghigi, Renato Micera, Anna Margherita Maffione, et al.Annals of Surgical Oncology|October 20, 2020
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant ChemoradiotherapyRoberta La Mendola, Maria Bencivenga, Lorena Torroni, et al.Cancers|December 8, 2020
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal CancerNicola Simoni, Michele Pavarana, Renato Micera, et al.Anticancer Research|September 29, 2020
Predictors of Local Control for Stereotactic Ablative Radiotherapy (SAbR) in Pulmonary Oligometastases from Gastrointestinal MalignanciesNicola Simoni, Renato Micera, Gabriella Rossi, et al.Frontiers in Oncology|December 17, 2020
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-RadiotherapyNicola Simoni, Gabriella Rossi, Giulio Benetti, et al.Frontiers in Oncology|January 4, 2021
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the BarRenzo Mazzarotto, Nicola Simoni, Stefania Guariglia, et al.Frontiers in Oncology|May 7, 2021
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic CancerGabriella Rossi, Nicola Simoni, Salvatore Paiella, et al.Pageof 2